5731 - 5740 of 8436 Results
Title
Year
-
RESTRICTEDTitle: Targeting the Dopaminergic System in AutoimmunityJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 57End Page: 73Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5Citation Count: 53
-
OPENTitle: miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signalingJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-018-1295-1Best OA location URL: https://www.nature.com/articles/s41419-018-1295-1.pdfCitation Count: 66
-
RESTRICTEDTitle: Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 148Issue #:Start Page: 220End Page: 228Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.01.015Citation Count: 14
-
RESTRICTEDTitle: Risk of Parkinson's disease dementia related to level I MDS PD‐MCIJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 3Start Page: 430End Page: 435Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27617Citation Count: 46
-
OPENTitle: Multimodal MRI evaluation of parkinsonian limbic pathologiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 194End Page: 200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.01.004Best OA location URL: https://europepmc.org/articles/pmc6461740?pdf=renderCitation Count: 14
-
OPENTitle: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 3Start Page: 1218End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294Best OA location URL: https://europepmc.org/articles/pmc6467782?pdf=renderCitation Count: 21
-
OPENTitle: Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinIONJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mgg3.564Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mgg3.564Citation Count: 76
-
OPENTitle: Identifying the neural correlates of doorway freezing in Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 7Start Page: 2055End Page: 2064Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.24506Best OA location URL: https://europepmc.org/articles/pmc6865388?pdf=renderCitation Count: 44
-
OPENTitle: Crystal structure of the WD40 domain dimer of LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 5Start Page: 1579End Page: 1584Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.1817889116Best OA location URL: https://www.pnas.org/content/pnas/116/5/1579.full.pdfCitation Count: 85
-
OPENTitle: Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved OutcomesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 3Start Page: 222End Page: 226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12724Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12724Citation Count: 1